Pregnancy and lactation: Cisplatin may be toxic to the foetus when administered to a pregnant woman. Animal studies have shown reproductive toxicity and transplacental carcinogenity.
During treatment with Cisplatin and for a minimum of the following 6 months, appropriate measures must be taken to avoid pregnancy; this applies to patients of both sexes.
Genetic consultation is recommended if the patient wishes to have children after ending the treatment.
Since a treatment with cisplatin may cause irreversible infertility, it is recommended that men, who wish to become fathers in the future, ask for advice regarding cryoconservation of their sperm prior to treatment.
Breast-feeding: Cisplatin is excreted in breast milk. Patients treated with cisplatin must not breastfeed.